#AAN2018: New Data Largely Supports Memantine Combo Easing Alzheimer’s Symptoms

#AAN2018: New Data Largely Supports Memantine Combo Easing Alzheimer’s Symptoms
New data on how Allergan’s Namenda (memantine) — given in combination with cholinesterase inhibitors — works to help ease some symptoms of Alzheimer’s disease will be presented at the American Academy of Neurology annual meeting in Los Angeles, April 21-27. The data, the results of five studies supported by Allergan, will be presented through scientific posters on April 27

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *